Bridgebio Pharma Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Bridgebio Pharma Inc
TickerBBIO
CIK #0001743881
CUSIP10806X102
SectorLife Sciences - Pharmaceutical Preparations
Address421 Kipling Street, Palo Alto, CA 94301
Source [EDGAR]
CIK Filing 2011 - 2025
[0001743881] 10-K
[0001743881] 10-Q
[0001743881] 3
[0001743881] 4
[0001743881] 5
[0001743881] 8-K
[0001743881] SC 13D
[0001743881] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
State Street Corp Bridgebio Pharma Inc [2023-02-08] 5.92
Vanguard Group Inc Bridgebio Pharma Inc [2021-02-10] 5.25
BlackRock Inc Bridgebio Pharma Inc [2021-02-05] 5.3
Eidos Therapeutics Inc Bridgebio Pharma Inc [2020-10-15] 36.4
American International Group Inc Bridgebio Pharma Inc [2020-02-14] 5.5
Kumar Neil Bridgebio Pharma Inc [2020-02-14] 6.98
Perceptive Advisors LLC Bridgebio Pharma Inc [2019-07-11] 5.5
KKR Genetic Disorder LP Bridgebio Pharma Inc [2019-07-10] 29.9
Viking Global Investors LP Bridgebio Pharma Inc [2019-07-08] 22.1
Bridgebio Pharma LLC Eidos Therapeutics Inc [2018-08-01] 54.8
Form 3/4/5 Filer 2011 - 2025
BridgeBio Pharma, Inc.
Apuli Maricel
Trimarchi Thomas
Kumar Neil
BridgeBio Pharma LLC
BridgeBio Oncology Therapeutics, Inc.
Homcy Charles J
Ellis Andrea
Viking Global Opportunities Portfolio GP LLC
Viking Global Opportunities Illiquid Investments Sub-Master
Viking Global Opportunities Parent GP LLC
Halvorsen Ole Andreas
Ott David C.
Shabet Rose Sharon
Viking Global Opportunities GP LLC
Viking Global Investors LP
Valantine Hannah
McCormick Frank
Lo Andrew
Cook Jennifer E.
Aguiar Eric
Daniels Ronald J
Satvat Ali J.
Momtazee James C
Hassan Fred
Dachille Douglas A.
Scott Randal W.
KKR Genetic Disorder GP LLC
Roberts George R
KKR & Co. Inc.
KKR Group Co. Inc.
KKR Group Partnership L.P.
KKR Management LLP
KKR Genetic Disorder L.P.
KKR Group Holdings Corp.
Kravis Henry R
Stephenson Brian C
Scheller Richard H
Saunders Brent L
Eidos Therapeutics, Inc.
Turtle Cameron
Sinha Uma
Henderson Michael Thomas
YAU YI Ching
Stolz Brian M.
KKR Management Holdings L.P.
KKR Management Holdings Corp
Viking Global Equities Master Ltd.
Viking Long Fund Master Ltd.
Viking Long Fund GP LLC
Viking Global Performance LLC
Form 13F Holdings
Firm Period DFND Voting Shares
Viking Global Investors LP [2025-06-30] SOLE 18,555,375 18,555,375
Vanguard Group Inc [2025-06-30] SOLE 0 16,126,179
BlackRock, Inc. [2025-06-30] SOLE 13,790,003 14,258,808
Kohlberg Kravis Roberts & Co LP [2025-06-30] OTR 0 13,260,971
Janus Henderson Group PLC [2025-06-30] DFND 0 9,276,532
Farallon Capital Management LLC [2025-06-30] OTR 7,900,000 7,900,000
UBS Group AG [2025-06-30] DFND 6,473,678 6,675,999
Aisling Capital Management LP [2025-06-30] SOLE 6,068,125 6,068,125
State Street Corp [2025-06-30] DFND 5,432,210 5,896,596
Jane Street Group LLC [2025-06-30] DFND 805,942 4,376,942
Susquehanna International Group LLP [2025-06-30] OTR 634,573 4,169,073
Capital Research Global Investors [2025-06-30] DFND 3,988,298 3,988,298
Frazier Life Sciences Management LP [2025-06-30] SOLE 3,800,457 3,800,457
Geode Capital Management LLC [2025-06-30] DFND 3,681,580 3,681,580
Invesco Ltd. [2025-06-30] DFND 0 2,801,065
Goldman Sachs Group Inc [2025-06-30] DFND 2,763,563 2,778,366
AllianceBernstein LP [2025-06-30] DFND 2,331,890 2,470,558
Laurion Capital Management LP [2025-06-30] SOLE 2,411,248 2,411,248
Two Sigma Investments LP [2025-06-30] SOLE 2,339,067 2,339,067
Macquarie Group Ltd [2025-06-30] SOLE 2,035,451 2,095,235
D. E. Shaw & Co., Inc. [2025-06-30] DFND 2,079,002 2,081,253
FMR LLC [2025-06-30] DFND 2,017,846 2,027,395
Norges Bank [2025-06-30] SOLE 1,956,654 1,956,654
Manufacturers Life Insurance Company the [2025-06-30] DFND 1,891,578 1,891,578
SC US TTGP Ltd [2025-06-30] DFND 1,860,364 1,860,364
Pictet Asset Management Holding SA [2025-06-30] SOLE 1,647,352 1,807,434
Balyasny Asset Management LP [2025-06-30] SOLE 1,743,520 1,743,520
Woodline Partners LP [2025-06-30] SOLE 1,704,800 1,704,800
Driehaus Capital Management LLC [2025-06-30] SOLE 1,393,452 1,691,213
Two Sigma Advisers LP [2025-06-30] SOLE 1,630,420 1,684,055
Prev | Page 3 | Next
Terms | Privacy | Guide
tony@aum13f.com